NO20023659L - Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser - Google Patents

Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser

Info

Publication number
NO20023659L
NO20023659L NO20023659A NO20023659A NO20023659L NO 20023659 L NO20023659 L NO 20023659L NO 20023659 A NO20023659 A NO 20023659A NO 20023659 A NO20023659 A NO 20023659A NO 20023659 L NO20023659 L NO 20023659L
Authority
NO
Norway
Prior art keywords
double
sebaceous gland
cholesterol ester
gland disorders
growth synthesis
Prior art date
Application number
NO20023659A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023659D0 (no
Inventor
Reynold Homan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20023659D0 publication Critical patent/NO20023659D0/no
Publication of NO20023659L publication Critical patent/NO20023659L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20023659A 2000-02-02 2002-08-01 Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser NO20023659L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17977800P 2000-02-02 2000-02-02
PCT/US2001/002190 WO2001056556A2 (fr) 2000-02-02 2001-01-23 Doubles inhibiteurs de la synthese d'ester de choslesteryle et d'ester de cire utilises dans le traitement des troubles des glandes sebacees

Publications (2)

Publication Number Publication Date
NO20023659D0 NO20023659D0 (no) 2002-08-01
NO20023659L true NO20023659L (no) 2002-09-25

Family

ID=22657957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023659A NO20023659L (no) 2000-02-02 2002-08-01 Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser

Country Status (34)

Country Link
US (2) US6730703B2 (fr)
EP (1) EP1263421B1 (fr)
JP (1) JP2003531113A (fr)
KR (1) KR20020073574A (fr)
CN (1) CN1398182A (fr)
AP (1) AP2002002612A0 (fr)
AT (1) ATE295724T1 (fr)
AU (1) AU781563B2 (fr)
BG (1) BG107042A (fr)
BR (1) BR0107954A (fr)
CA (1) CA2398219A1 (fr)
CR (1) CR6712A (fr)
DE (1) DE60110897T2 (fr)
DZ (1) DZ3288A1 (fr)
EA (1) EA004255B1 (fr)
EE (1) EE200200429A (fr)
ES (1) ES2239145T3 (fr)
GE (1) GEP20043286B (fr)
HR (1) HRP20020717A2 (fr)
HU (1) HUP0301010A3 (fr)
IL (1) IL150865A0 (fr)
IS (1) IS6478A (fr)
MA (1) MA26872A1 (fr)
MX (1) MXPA02007309A (fr)
NO (1) NO20023659L (fr)
NZ (1) NZ520330A (fr)
OA (1) OA12173A (fr)
PL (1) PL357041A1 (fr)
PT (1) PT1263421E (fr)
SK (1) SK10972002A3 (fr)
UA (1) UA75345C2 (fr)
WO (1) WO2001056556A2 (fr)
YU (1) YU57502A (fr)
ZA (1) ZA200206075B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281399A3 (fr) * 2001-08-01 2004-02-11 Warner-Lambert Company Inhibiteurs doubles de la synthèse des des esters de cires et des esters du cholestérol pour inhiber la production de sébum
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
ES2313065T3 (es) 2003-10-09 2009-03-01 Warner-Lambert Company Llc Composiciones farmaceuticas que comprenden derivados de malonamida para disminuir la produccion de sebo.
KR100906288B1 (ko) 2005-02-24 2009-07-06 워너-램버트 캄파니 엘엘씨 결정질 ａｃａｔ 억제제
FR2904002A1 (fr) * 2006-07-19 2008-01-25 Galderma Res & Dev S N C Snc Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2938342A1 (fr) * 2008-11-13 2010-05-14 Galderma Res & Dev Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
CA2750233A1 (fr) 2009-01-28 2010-08-05 Nanobio Corporation Composition pour le traitement et la prevention de l'acne, procedes de fabrication des compositions, et procedes d'utilisation associes
JP2021527634A (ja) * 2018-06-21 2021-10-14 デルマバント サイエンシズ ゲーエムベーハー Ｄｇａｔ１阻害剤の局所製剤およびそれらの使用の方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US4751026A (en) 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase
US4722927A (en) 1986-04-28 1988-02-02 Warner-Lambert Company Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
EP0252524A3 (fr) 1986-07-11 1989-04-19 Warner-Lambert Company Dérivés d'aryl- et aralkylamide d'acides oméga-(phényloxy substitué)-alcanoiques comme inhibiteurs d'acyl-CoA: cholestérol-acyltransférase et compositions pharmaceutiques les contenant
US4716175A (en) 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US5015644A (en) 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
IE61716B1 (en) 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
EP0297610B1 (fr) 1987-07-02 1991-03-13 Warner-Lambert Company N-[(phényl 2,6-substitué)urées]-carbamates inhibiteurs de l'acyl-co-enzyme A:cholestérol-acyltransférase
US5030653A (en) 1988-03-30 1991-07-09 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4999373A (en) 1988-03-30 1991-03-12 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5116848A (en) 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US4948806A (en) 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4923896A (en) 1989-02-09 1990-05-08 Warner-Lambert Company N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US5155127A (en) 1989-02-09 1992-10-13 Warner-Lambert Company N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4994465A (en) 1989-02-17 1991-02-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU632809B2 (en) 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
CA2022346A1 (fr) 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation Derives de 1-phenylalkyl-3-phenyluree
WO1991004027A1 (fr) 1989-09-15 1991-04-04 Pfizer Inc. Nouveaux derives de n-aryle de n-heteroarylamide et d'uree en tant qu'inhibiteurs d'acyl coenzyme a: cholesterol acyl transferase
TW205037B (fr) 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd
JPH05310678A (ja) 1990-01-22 1993-11-22 Mitsubishi Kasei Corp １−フェニルアルキル−３−フェニル尿素誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
JP2668163B2 (ja) 1992-01-23 1997-10-27 ファイザー インク． コレステロール血症および抗アテローム動脈硬化症薬としての４−アリール−３−（ヘテロアリールウレイド）−１，２−ジヒドロ−２−オキソ−キノリン誘導体
WO1993024458A1 (fr) 1992-05-28 1993-12-09 Pfizer Inc. Nouveau derives n-aryle et de n-heteroaryluree en tant qu'inhibiteurs de l'acylcoenzime a: cholesterol acyltransferase (acat)
US5565472A (en) 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US5596001A (en) 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
US5494172A (en) * 1994-05-12 1996-02-27 Miller Compressing Company Magnetic pulley assembly
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
AU763687B2 (en) * 1998-06-25 2003-07-31 Tularik Inc. Arylsulfonanilide phosphates
PE20020453A1 (es) * 2000-09-27 2002-06-06 Merck & Co Inc Derivados del acido benzopirancarboxilico para el tratamiento de la diabetes y los trastornos de lipidos

Also Published As

Publication number Publication date
EA004255B1 (ru) 2004-02-26
EE200200429A (et) 2003-12-15
WO2001056556A3 (fr) 2002-03-07
MXPA02007309A (es) 2002-11-29
GEP20043286B (en) 2004-07-26
PL357041A1 (en) 2004-07-12
OA12173A (en) 2006-05-08
CR6712A (es) 2004-01-14
MA26872A1 (fr) 2004-12-20
IL150865A0 (en) 2003-02-12
HUP0301010A2 (hu) 2003-08-28
EA200200764A1 (ru) 2002-12-26
BG107042A (bg) 2003-04-30
SK10972002A3 (sk) 2003-07-01
IS6478A (is) 2002-07-19
BR0107954A (pt) 2002-10-22
CN1398182A (zh) 2003-02-19
PT1263421E (pt) 2005-08-31
CA2398219A1 (fr) 2001-08-09
US20040161393A1 (en) 2004-08-19
DE60110897D1 (de) 2005-06-23
US6730703B2 (en) 2004-05-04
KR20020073574A (ko) 2002-09-27
AP2002002612A0 (en) 2002-09-30
ES2239145T3 (es) 2005-09-16
ZA200206075B (en) 2003-10-30
NO20023659D0 (no) 2002-08-01
YU57502A (sh) 2006-01-16
AU2971801A (en) 2001-08-14
NZ520330A (en) 2004-02-27
EP1263421B1 (fr) 2005-05-18
AU781563B2 (en) 2005-06-02
ATE295724T1 (de) 2005-06-15
EP1263421A2 (fr) 2002-12-11
JP2003531113A (ja) 2003-10-21
DE60110897T2 (de) 2006-03-23
DZ3288A1 (en) 2001-08-09
WO2001056556A2 (fr) 2001-08-09
UA75345C2 (en) 2006-04-17
HUP0301010A3 (en) 2005-03-29
HRP20020717A2 (en) 2003-12-31
US20030060507A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
NO20031152D0 (no) Befruktningshindrende fremgangsmåte og administrasjonsform for det samme
NO20025377L (no) Fremgangsmate for fremstilling av dihydroksyestere og derivater derav
IS6254A (is) Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
NO20021382D0 (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
NO20025585L (no) Inhibitorer for 11-beta-hydroxy steroid dehydrogenase type 1
NO20012911L (no) Fremvisningsanordning og fremgangsmåte for drift av samme
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
EP1259191A4 (fr) Ensemble extenseur temporaire pour interventions chirurgicales
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
ITMI20011269A0 (it) Pannello isolante e procedimento per la sua realizzazione
NO20023659D0 (no) Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20034994D0 (no) Fremgangsmåte for å uttrykke langkjedet prenyldifosfatsyntese
AU2001274413A1 (en) Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
DE60008319D1 (de) IL-12 Produktionsinhibitor
DK1263421T3 (da) Den dobbelte inhibitor af cholesterylester- og voksestersyntese avasimibe til behandling af talgkirtel-lidelser
AU2002218555A1 (en) Operation system of exhibition site for internet
NO20015760L (no) Fibrinforseglinger som tilveiebringer mindre betennelsesrespons og fremgangsmater for bruk av samme
NO20031847D0 (no) Sammensetninger og fremgangsmåte for oppdagelse og seleksjon av biologisk informasjon
NO20035297D0 (no) Fremgangsmåte for fremvisning av data
IT1317859B1 (it) Metodo per la selezione e la crescita di oociti competenti per losviluppo embrionale.
AU2002257602A1 (en) Simple method for the synthesis of boswellic acids and derivatives thereof
ITMI981669A0 (it) Mensola di sostegno e procedimento per la sua produzione

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application